logo

Tarsus Pharmaceuticals Inc (TARS) Stock: Navigating Market Highs and Lows in 52 Weeks

PNC Stock

The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. Tarsus Pharmaceuticals Inc’s current trading price is -27.92% away from its 52-week high, while its distance from the 52-week low is 105.61%. The stock’s price range for this period has been between $20.08 and $57.28 The company’s shares, which are part of the Healthcare sector, had a trading volume of approximately 1.78 million for the day, a number notably higher than the average daily volume of 0.57 million over the last three months.

Tarsus Pharmaceuticals Inc saw a rather consistency, in terms of market performance. The company’s stock reached its highest point at $57.28 on 02/05/25, while the lowest price for the same duration was marked at $20.08 on 08/05/24.

Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis

Tarsus Pharmaceuticals Inc (TARS) has experienced a quarterly decline of -11.36% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 1.58B and boasts a workforce of 244 employees.

Analyzing Trading Volume and Moving Average Trends

Based on Barchart.com data, the company’s moving average over the 100-day period was 47.35, with a change in price of +8.40. Similarly, Tarsus Pharmaceuticals Inc recorded 676,098 in trading volume during the last 100 days, posting a change of +25.54%.

Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis

The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for TARS stands at 0.30. Similarly, the long-term debt-to-equity ratio is also 0.30.

TARS Stock Stochastic Average

As of today, Tarsus Pharmaceuticals Inc’s raw stochastic average for the last 50 days stands at 5.22%. This is a rise compared to the raw stochastic average of the previous 20 days, which was noted at 5.22%. Furthermore, the company’s Stochastic %K and %D values for the past 20 days were 4.27% and 8.97%, respectively.

TARS Stock Price Performance Analysis

A mixed performance in the stock price over the year has left investors with either an optimistic or pessimistic outlook, depending on their point of view. The index has shown a price loss of -25.43% this year. Over the last six months, there has been a weaker performance of 63.14%. The price of TARS leaped by -15.35% during the last 30 days period. For the last 5-days stocks have slided -18.80%.

Most Popular